Servier and Day One Biopharmaceuticals announced an acquisition to expand Servier's portfolio in rare oncology. Did you miss out on the acquisition price of $21.50?😂$Day One Biopharmaceuticals(DAWN.US)
Day One Biopharmaceuticals
DAWN21.5300.00% ( 0.000 )
Share your thoughts
Write something you'd like to share with our community...
- D
Rivian: Narrowing Losses, R2 Mass Production Imminent, Is Rivian's Dawn Approaching?
Successfully climbed out of the second quarter loss mire
+3
RivianFinancial Analysis
